Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy)
Article
[키워드] Accuracy
addition
adjuvant
advance
adverse events
Algorithm
anti-CTLA-4
Anti-PD-1
approach
approved
Biomarker
Biomarkers
biopsy
BRAF
BRAF inhibitor
bridge
cancers
Cell
characterized
Chemotherapy
clinically
Combination
Combination strategies
combination therapy
combination treatment
COVID-19 pandemic
development
Diagnosis
Drug administration
Efficacy
effort
Evidence
feature
genomic
help
Host immune response
immune
Immune checkpoint inhibitor
immune response
Immunotherapy
improve diagnostics
Improved
Italy
lesions
management
mechanism
mechanism of action
MEK inhibitor
Melanoma
Naples
Neoadjuvant
oncogenic
overcome
Patient
patients
platform
Precision
predict
Predictive
Radiotherapy
Research
robust
specific treatment
survival
systemic and local
target
target therapy
tested
therapeutic
therapeutic agent
therapy
translational
treatment regimens
tumor immunity
tumor microenvironment
Vaccine
viruses
[DOI] 10.1186/s12967-022-03592-4 PMC 바로가기
[DOI] 10.1186/s12967-022-03592-4 PMC 바로가기